Negative regulation of MAVS-mediated innate immune response by PSMA7

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4241-4248

  Jia, Yongxia ^a   Song, Ting ^a   Wei, Congwen ^a   Ni, Caifei ^a   Zheng, Zirui ^a   Xu, Quanbin ^a   Ma, Hongfang ^a   Li, Li ^a   Zhang, Yanhong ^a   He, Xiang ^b   Xu, Yang ^c   Shi, Wei ^a,c   Zhong, Hui ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; OUTER MEMBRANE PROTEIN; PROTEASOME; PROTEIN MITOCHONDRIAL ANTIVIRAL SIGNALING; PSMA7 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; NLRX1 PROTEIN, HUMAN; PROTEIN SUBUNIT; PSMA7 PROTEIN, HUMAN; RRIG1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; VISA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GENE OVEREXPRESSION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; MEMBRANE PROTEINS; MICE; MITOCHONDRIAL PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; TUMOR SUPPRESSOR PROTEINS; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 70449725290     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901646     Document Type: Article

References (42)

1. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
2. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7: 131-137. (Pubitemid 43135878)
3. Perry, A. K., G. Chen, D. Zheng, H. Tang, and G. Cheng. 2005. The host type I interferon response to viral and bacterial infections. Cell Res. 15: 407-422.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signaling. Nat. Rev. Immunol. 4: 499-511.
5. Meylan, E., and J. Tschopp. 2006. Toll-like receptors and RNA helicases:two parallel ways to trigger antiviral responses. Mol. Cell 22: 561-569. (Pubitemid 43817607)
6. Fritz, J. H., R. L. Ferrero, D. J. Philpott, and S. E. Girardin. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7: 1250-1257.
7. Inohara, N., and G. Nunez. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3: 371-382. (Pubitemid 37323197)
8. Inohara, N., M. Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74: 355-383. (Pubitemid 40995511)
9. Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26: 447-454. (Pubitemid 41008082)
10. Kumar, H., T. Kawai, H. Kato, S. Sato, K. Takahashi, C. Coban, M. Yamamoto, S. Uematsu, K. J. Ishii, and O. Takeuchi. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203: 1795-1803. (Pubitemid 44036284)
11. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, and O. Takeuchi. 2005. Cell type specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. (Pubitemid 41019654)
12. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, and K. J. Ishii. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
13. Kawai, T., K. Takahashi, and S. Sato. 2005. An adaptor triggering RIG-1 and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.
14. Yoneyama, M., M. Kikuchi, and T. Natsukawa. 2004. The RNA helicase RIG-1 has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
15. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122: 669-682.
16. Hiscott, J., R. Lin, P. Nakhaei, and S. Paz. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12: 2-10.
17. Sun, Q., L. Sun, and H. H. Liu. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24: 633-642.
18. Qi, B., Y. Huang, D. Rowe, and G. Halliday. 2007. VISA: a pass to innate immunity. J. Biol. Chem. 39: 287-291.
19. Xu, L. G., Y. Y. Wang, and K. J. Han. 2005. VISA is an adaptor protein required for virus-triggered IFN-β signaling. Mol. Cell 19: 727-740.
20. Moore, C. B., D. T. Bergstralh, J. A. Duncan, Y. Lei, T. E. Morrison, A. G. Zimmermann, M. A. Accavitti-Loper, V. J. Madden, L. Sun, and Z. Ye. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-579.
21. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68: 1051-1068.
22. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65: 801-847. (Pubitemid 26255262)
23. Varshavsky, A. 2005. Regulated protein degradation. Trends Biochem. Sci. 30: 283-286.
24. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome:a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68: 1051-1068. (Pubitemid 29449214)
25. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428.
26. Cho, S., Y. Choi, J. Kim, S. Jeong, J. Kim, S. Kim, and S. Ryu. 2001. Binding and regulation of HIF-1a by a subunit of the proteasome complex PSMA7. FEBS Lett. 498: 62-66. (Pubitemid 32522892)
27. Hu, Z., Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, and T. J. Liang. 1999. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome comoplex. J. Virol. 73: 7231-7240. (Pubitemid 29383204)
28. Huang, J., J. Kwong, E. C.-Y. Sun, and T. J. Liang. 1996. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J. Virol. 70: 5582-5591. (Pubitemid 26240735)
29. Fruh, K., M. Gossen, K. Wang, H. Bujard, P. A. Peterson, and Y. Yang. 1994. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13: 3236-3244. (Pubitemid 24226938)
30. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68: 1015-1068. (Pubitemid 29449214)
31. Borissenko, L., and M. Groll. 2007. 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem. Rev. 107: 687-717. (Pubitemid 46502369)
32. Cortid, O., C. Hamped, N. Patengee, K. Vaupela, A. Yamamotof, M. Dichgansa, A. Briced, E. E. Wankerc, P. J. Kahlee, and T. Gassere. 2005. Parkin interacts with the proteasome subunit α4. FEBS Lett. 579: 3913-3919.
33. Kahle, P. J., and C. Haass. 2004. How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep. 5: 681-685.
34. Ben-Neriah, Y. 2002. Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3: 20-26. (Pubitemid 34065613)
35. Finley, D., A. Ciechanover, and A. Varshavsky. 2004. Ubiquitin as a central cellular regulator. Cell 116: S29-S32.
36. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67: 425-479.
37. Liu, Y. C. 2004. Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22: 81-127.
38. Kumatori, A., K. Tanaka, N. Inamura, S. Sone, T. Ogura, T. Matsumoto, T. Tachikawa, S. Shin, and A. Ichihara. 1990. Abnormally high expression of proteasomes in human leukemia cells. Proc. Natl. Acad. Sci. USA 87: 7071-7075.
39. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731.
40. Kane, R. C., P. F. Bross, A. T. Farrell, and R. Pazdur. 2003. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 8: 508-513.
41. Yang, H., D. Chen, Q. C. Cui, X. Yuan, and Q. P. Dou. 2006. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 66: 4758-4765.
42. Yang, H., G. Shi, and Q. P. Dou. 2007. The tumor proteasome is a primary target for the natural anticancer compound isolated from "Indian winter cherry". Mol. Pharmacol. 71: 426-437.